201 filings
Page 8 of 11
6-K
2oxe13q
21 Sep 18
Current report (foreign)
8:05am
6-K
6803pzqq i82
18 Sep 18
Current report (foreign)
12:00am
6-K
21yhrcfso
30 Aug 18
Current report (foreign)
12:00am
6-K
hrir4b7ahqpqk0 41
14 Aug 18
Current report (foreign)
4:09pm
6-K
mwtcoe
8 Aug 18
UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Officer
1:46pm
6-K
vhporcd
12 Jul 18
UroGen Pharma Appoints Shawn Cline Tomasello to its Board of Directors
8:07pm
6-K
o5vpn03 rvh
6 Jun 18
UroGen Pharma Announces Stephen Mullennix as Interim Chief Financial Officer and Jason Patel as Vice President of Finance
2:03pm
6-K
f6k89r dm31y
6 Jun 18
Current report (foreign)
2:01pm
6-K
rrpq5jwt8w29atjsn
15 May 18
Current report (foreign)
4:24pm
6-K
j1fd432fpzh3ac
25 Apr 18
Current report (foreign)
4:04pm
6-K
rqt gmi1hzj7lwl59e
4 Apr 18
Current report (foreign)
12:00am
6-K
8j0ztppcj7ekoxn13
16 Mar 18
UroGen Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
20-F
cud1gywa9e4cuo 8zmoa
15 Mar 18
Annual report (foreign)
12:00am
6-K
tk1 4pa76a5vc
20 Feb 18
Current report (foreign)
12:00am
6-K
q3rhaf sgq
14 Feb 18
UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as Chief Operating Officer
12:00am
S-8
pv4d75xjoyhk0u0i
9 Feb 18
Registration of securities for employees
12:00am
424B4
laaq510apflw9l
22 Jan 18
Prospectus supplement with pricing info
12:00am
F-1MEF
5neds07h024s29
18 Jan 18
Registration statement to add securities to prior F-1 registration
12:00am
EFFECT
cvsg2ehtd0a sr9
18 Jan 18
Notice of effectiveness
12:00am
F-1
kh47mg
16 Jan 18
Registration statement (foreign)
12:00am